MDMA, commonly known as ecstasy, is a recreational psychedelic drug often used at parties and dance clubs because it creates feelings of closeness and social connection with others. Because of this ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy. By ...

Long-term (over 1 year) follow-up reflects lasting improvements in symptom severity. Data confirms prior Phase 2 studies on MDMA-assisted therapy’s sustained effect on PTSD treatment. New Drug ...

FDA staff raised concerns about the available safety data and limitations in the study design for midomafetamine (MDMA) to treat post-traumatic stress disorder (PTSD) in briefing documents released ...

The University of Colorado is the latest mainstream university to create a dedicated center for the study of psychedelic drugs, and its leaders are already dreaming up new experiments. The CU Denver ...

"Yes, It's Trippy," from the visual journals of Cathy Malchiodi, PhD Source: ©2023 Cathy Malchiodi PhD, shared with permission. Self-experience is arguably at the center of all approaches to ...

Ahead of a key meeting Tuesday to weigh the potential approval of midomafetamine, or MDMA, for patients with post-traumatic stress disorder, the Food and Drug Administration is proposing a new set of ...

Some call the drug "ecstasy" or "molly." Researchers are calling it a potential tool to help treat loneliness. As public health experts sound the alarm on a rising loneliness epidemic in the United ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. First, let me ...